4.6 Article

Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer

Ulla Klaiber et al.

Summary: In patients undergoing resection after neoadjuvant therapy for initially unresectable PDAC, preoperative CA 19-9 levels, lymph node involvement, metastasis category, and vascular involvement, but not the R status, were independent prognostic factors of overall survival.

ANNALS OF SURGERY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review

Florentine E. F. Timmer et al.

Summary: Metastatic pancreatic ductal adenocarcinoma (mPDAC) has a poor prognosis, but in selected patients, locoregional therapy may improve survival. Radical-intent local therapy for primary and metastatic sites showed superior survival compared to chemotherapy, but further research and randomized controlled trials are needed for definitive recommendations.

CANCERS (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Gastroenterology & Hepatology

Fifty Years of Surgery for Pancreatic Cancer

Thilo Hackert et al.

PANCREAS (2020)

Article Oncology

Proposal for a definition of Oligometastatic disease in pancreatic cancer

Alexander I. Damanakis et al.

BMC CANCER (2019)

Review Oncology

Optimizing the outcomes of pancreatic cancer surgery

Oliver Strobel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Oncology

The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma

Andreas Andreou et al.

SURGICAL ONCOLOGY-OXFORD (2018)

Review Gastroenterology & Hepatology

Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation

Ilenia Bartolini et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Biochemistry & Molecular Biology

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

Aleksandra Adamska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Oncology

Neuroendocrine liver metastasis: The chance to be cured after liver surgery

Fabio Bagante et al.

JOURNAL OF SURGICAL ONCOLOGY (2017)

Article Oncology

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

Isabella Frigerio et al.

ANNALS OF SURGICAL ONCOLOGY (2017)

Article Surgery

Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma

D. Ansari et al.

BRITISH JOURNAL OF SURGERY (2017)

Article Surgery

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

Guopei Luo et al.

ANNALS OF SURGERY (2017)

Article Oncology

Radical surgery of oligometastatic pancreatic cancer

T. Hackert et al.

Article Oncology

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Davendra P. S. Sohal et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Oncology

Treatment of Neuroendocrine Liver Metastases

Heather A. Farley et al.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)

Article Gastroenterology & Hepatology

Role of surgery in colorectal cancer liver metastases

Ozgur Akgul et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Oncology

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?

Emmanuel Buc et al.

World Journal of Surgical Oncology (2014)

Review Gastroenterology & Hepatology

Therapeutic Advances in Pancreatic Cancer

Andrew Scott Paulson et al.

GASTROENTEROLOGY (2013)

Article Gastroenterology & Hepatology

Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma

Teiichi Sugiura et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2012)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Oncology

Perioperative management of pancreatic cancer

V. Heinemann et al.

ANNALS OF ONCOLOGY (2008)

Article Surgery

National failure to operate on early stage pancreatic cancer

Karl Y. Bilimoria et al.

ANNALS OF SURGERY (2007)

Review Gastroenterology & Hepatology

Surgical therapy for colorectal metastases to the liver

Timothy M. Pawlik et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2007)

Article Oncology

Pancreatic resection for M1 pancreatic ductal adenocarcinoma

Shailesh V. Shrikhande et al.

ANNALS OF SURGICAL ONCOLOGY (2007)

Article Medicine, General & Internal

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

JP Neoptolemos et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Social Sciences, Mathematical Methods

Multimodel inference - understanding AIC and BIC in model selection

KP Burnham et al.

SOCIOLOGICAL METHODS & RESEARCH (2004)

Article Oncology

A 5-decade analysis of 13,715 carcinoid tumors

IM Modlin et al.

CANCER (2003)